These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

54 related items for PubMed ID: 2079473

  • 21. Dietary n-3 fatty acids and children with hyperlipidaemia.
    Ose L, Grønn M, Levorsen A, Trygstad O, Lund H, Wiig I.
    J Intern Med Suppl; 1989; 731():181-3. PubMed ID: 2706040
    [Abstract] [Full Text] [Related]

  • 22. Practical drug therapy for common hyperlipidaemias.
    Tikkanen MJ.
    Baillieres Clin Endocrinol Metab; 1990 Dec; 4(4):719-42. PubMed ID: 2082904
    [No Abstract] [Full Text] [Related]

  • 23. Treatment of hyperlipidemia in renal transplant patients with gemfibrozil and dietary modification.
    Knight RJ, Vathsala A, Schoenberg L, Camel S, Weinberg RB, Goldstein RA, Lewis RM, van Buren CT, Kahan BD.
    Transplantation; 1992 Jan; 53(1):224-5. PubMed ID: 1733073
    [No Abstract] [Full Text] [Related]

  • 24. Calculating LDL cholesterol in familial combined hyperlipidemia: Out with the old, in with the new?
    Martin SS.
    Atherosclerosis; 2018 Oct; 277():172-174. PubMed ID: 30166207
    [No Abstract] [Full Text] [Related]

  • 25. An interaction between Gemfibrozil and alpha 1-antitrypsin.
    Janciauskiene S, Eriksson S.
    J Intern Med; 1994 Sep; 236(3):357-60. PubMed ID: 8077896
    [Abstract] [Full Text] [Related]

  • 26. Familial combined hyperlipoproteinemia.
    Spence JD.
    CMAJ; 1992 Feb 15; 146(4):436, 438. PubMed ID: 1737299
    [No Abstract] [Full Text] [Related]

  • 27. Endocrine diseases as causes of secondary hyperlipidemia.
    Bułdak Ł, Marek B, Kajdaniuk D, Urbanek A, Janyga S, Bołdys A, Basiak M, Maligłówka M, Okopień B.
    Endokrynol Pol; 2019 Feb 15; 70(6):511-519. PubMed ID: 31891414
    [Abstract] [Full Text] [Related]

  • 28. Clinical therapy and trials.
    Chudleigh R, Platts J.
    Curr Opin Lipidol; 2004 Apr 15; 15(2):235-7. PubMed ID: 15017370
    [No Abstract] [Full Text] [Related]

  • 29. Primary hyperlipidaemia.
    Thompson GR.
    Br Med Bull; 1990 Oct 15; 46(4):986-1004. PubMed ID: 2100694
    [Abstract] [Full Text] [Related]

  • 30. Familial combined hyperlipidaemia: 1973-1991.
    Castro Cabezas M, de Bruin TW, Erkelens DW.
    Neth J Med; 1992 Feb 15; 40(1-2):83-95. PubMed ID: 1579191
    [No Abstract] [Full Text] [Related]

  • 31. Interaction Between Primary Hyperlipidemias and Type 2 Diabetes: Therapeutic Implications.
    Zubirán R, Cruz-Bautista I, Aguilar-Salinas CA.
    Diabetes Ther; 2024 Sep 15; 15(9):1979-2000. PubMed ID: 39080218
    [Abstract] [Full Text] [Related]

  • 32. An unusual case of familial hyperlipidaemia.
    Nagar R, Arora U.
    Indian J Clin Biochem; 2008 Jul 15; 23(3):302-4. PubMed ID: 23105777
    [Abstract] [Full Text] [Related]

  • 33. Classification of hyperlipidaemias -- a time for review?
    Asmal AC, Leary WP.
    S Afr Med J; 1976 Nov 27; 50(51):2022. PubMed ID: 1006478
    [No Abstract] [Full Text] [Related]

  • 34. Gemfibrozil in familial and type V hyperlipidaemias. Report of 3 cases.
    Varthakavi P, Turakhia DP, Sharma S, Salgaonkar DS, Nihalani KD, Joshi VR.
    J Assoc Physicians India; 1990 Nov 27; 38(11):860-2. PubMed ID: 2079473
    [Abstract] [Full Text] [Related]

  • 35. Gemfibrozil in hyperlipidaemia: an open, single blind trial.
    Varthakavi PK, Turakhia DP, Sharma SS, Salgaonkar DS, Nihalani KD, Joshi VR.
    J Assoc Physicians India; 1990 Feb 27; 38(2):136-40. PubMed ID: 2380132
    [Abstract] [Full Text] [Related]

  • 36. Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia.
    Athyros VG, Papageorgiou AA, Avramidis MJ, Kontopoulos AG.
    Coron Artery Dis; 1995 Mar 27; 6(3):251-6. PubMed ID: 7788039
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
    Wolf HR.
    Drugs Exp Clin Res; 1994 Mar 27; 20(3):109-13. PubMed ID: 7956717
    [Abstract] [Full Text] [Related]

  • 38. [Treatment of familial combined hyperlipidemia].
    Bruckert E.
    Ann Endocrinol (Paris); 1997 Mar 27; 58(4):297-301. PubMed ID: 9436478
    [No Abstract] [Full Text] [Related]

  • 39. Gemfibrozil in familial and type V hyperlipidaemias. Report of 3 cases.
    Varthakavi P, Turakhia DP, Sharma S, Salgaonkar DS, Nihalani KD, Joshi VR.
    J Assoc Physicians India; 1990 Nov 27; 38(11):860-2. PubMed ID: 2079473
    [Abstract] [Full Text] [Related]

  • 40. Gemfibrozil in hyperlipidaemia: an open, single blind trial.
    Varthakavi PK, Turakhia DP, Sharma SS, Salgaonkar DS, Nihalani KD, Joshi VR.
    J Assoc Physicians India; 1990 Feb 27; 38(2):136-40. PubMed ID: 2380132
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.